Research
August 5, 2026
JACKSONVILLE, Fla. — Mayo Clinic researchers have developed an experimental drug with the help of artificial intelligence (AI) to target the "undruggable" PDZ-domain of GIPC1[...]
September 16, 2025
September 9, 2025
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community